Chaoxia Zou

1.3k total citations
35 papers, 926 citations indexed

About

Chaoxia Zou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chaoxia Zou has authored 35 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Chaoxia Zou's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (7 papers). Chaoxia Zou is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (7 papers). Chaoxia Zou collaborates with scholars based in China, United States and Kenya. Chaoxia Zou's co-authors include Xu Gao, Chendan Zou, Xishan Wang, Jianfeng Jin, Hanqing Hu, Guiyu Wang, Ziming Yuan, Guixiang Lv, Qiang Li and Runkun Yang and has published in prestigious journals such as Nucleic Acids Research, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Chaoxia Zou

35 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaoxia Zou China 16 673 520 127 91 66 35 926
Xiaohong Zhang China 17 600 0.9× 521 1.0× 88 0.7× 71 0.8× 92 1.4× 35 841
Gui Ma China 18 675 1.0× 419 0.8× 135 1.1× 103 1.1× 70 1.1× 35 959
Mingsong Wang China 17 549 0.8× 284 0.5× 106 0.8× 67 0.7× 50 0.8× 33 761
Jianjun Yang China 17 922 1.4× 653 1.3× 150 1.2× 63 0.7× 95 1.4× 35 1.2k
Xiaobing Chen China 15 546 0.8× 344 0.7× 114 0.9× 81 0.9× 78 1.2× 43 817
Ge Lou China 15 585 0.9× 333 0.6× 109 0.9× 66 0.7× 54 0.8× 33 796
Xiaobo Cui China 18 574 0.9× 319 0.6× 210 1.7× 55 0.6× 66 1.0× 49 864
Dan Fan China 10 525 0.8× 346 0.7× 116 0.9× 52 0.6× 38 0.6× 19 793

Countries citing papers authored by Chaoxia Zou

Since Specialization
Citations

This map shows the geographic impact of Chaoxia Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaoxia Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaoxia Zou more than expected).

Fields of papers citing papers by Chaoxia Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaoxia Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaoxia Zou. The network helps show where Chaoxia Zou may publish in the future.

Co-authorship network of co-authors of Chaoxia Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Chaoxia Zou. A scholar is included among the top collaborators of Chaoxia Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaoxia Zou. Chaoxia Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yang, Yang Li, Linlin Wang, et al.. (2024). Prolyl isomerase Pin1 sculpts the immune microenvironment of colorectal cancer. Cellular Signalling. 115. 111041–111041. 9 indexed citations
2.
Zou, Chendan, Yuan Yu, Hefei Wang, et al.. (2023). Juglone Inhibits Tumor Metastasis by Regulating Stemness Characteristics and the Epithelial-to-Mesenchymal Transition in Cancer Cells both in Vitro and in Vivo. Frontiers in Bioscience-Landmark. 28(2). 26–26. 3 indexed citations
3.
An, Qiang, Wei Yao, Wei Yao, et al.. (2023). CircRRAS2 promotes myogenic differentiation of bovine MuSCs and is a novel regulatory molecule of muscle development. Animal Biotechnology. 34(9). 4783–4792. 2 indexed citations
4.
Pan, Yu, Chaoxia Zou, Qiang An, et al.. (2022). CircUBE2Q2 promotes differentiation of cattle muscle stem cells and is a potential regulatory molecule of skeletal muscle development. BMC Genomics. 23(1). 267–267. 12 indexed citations
5.
Yuan, Ziming, Hanqing Hu, Yihao Zhu, et al.. (2021). Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-κB pathway to promote metastasis. Cell Death and Disease. 12(6). 543–543. 30 indexed citations
6.
Zhang, He, Chongyang Wang, Yuanli Liu, et al.. (2021). CPEB3 deficiency in mice affect ovarian follicle development and causes premature ovarian insufficiency. Cell Death and Disease. 13(1). 21–21. 16 indexed citations
7.
Wang, Hefei, Chendan Zou, Weiyang Zhao, et al.. (2019). Juglone eliminates MDSCs accumulation and enhances antitumor immunity. International Immunopharmacology. 73. 118–127. 22 indexed citations
8.
Li, Qiang, Qi Liu, Wanpeng Cheng, et al.. (2019). Heme Oxygenase-1 Inhibits Tumor Metastasis Mediated by Notch1 Pathway in Murine Mammary Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 27(6). 643–651. 11 indexed citations
9.
Zhang, Yongjian, He Zhang, Chao Zhan, et al.. (2018). CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 46–46. 57 indexed citations
10.
Hu, Hanqing, Meng Wang, Xu Guan, et al.. (2018). Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer. Bioscience Reports. 38(1). 15 indexed citations
11.
Hu, Shaofan, Ke Shi, Ming Jiang, et al.. (2015). A Single Fas Gene Mutation Changes Lupus Onset, Severity, Location, and Molecular Abnormalities in Mice. Current Molecular Medicine. 15(4). 380–385. 2 indexed citations
12.
Zhang, Weidong, Yanling Zhang, Ke Shi, et al.. (2014). Multi-modality imaging to determine the cellular heterogeneity of nasopharyngeal carcinoma components. Oncotarget. 5(8). 2221–2229. 2 indexed citations
13.
Shi, Ke, Jason T. Yustein, Shaozeng Zhang, et al.. (2013). Multiple Target-Specific Molecular Agents for Detection and Image Analysis of Breast Cancer Characteristics in Mice. Current Molecular Medicine. 13(3). 446–458. 5 indexed citations
14.
Li, Qiang, Chaoxia Zou, Chendan Zou, et al.. (2013). MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Letters. 335(1). 168–174. 102 indexed citations
15.
Shi, Ke, et al.. (2012). Multiple Target-Specific Molecular Imaging Agents Detect Liver Cancer in a Preclinical Model. Current Molecular Medicine. 12(8). 944–951. 5 indexed citations
16.
Yang, Hui, Yanli Zhao, Ning Ma, et al.. (2012). M3-mAChR Stimulation Exerts Anti-apoptotic Effect Via Activating the HIF-1α/HO-1/VEGF Signaling Pathway in H9c2 Rat Ventricular Cells. Journal of Cardiovascular Pharmacology. 60(5). 474–482. 12 indexed citations
17.
Qiao, Yu, Ning Ma, Xidi Wang, et al.. (2011). MiR-483-5p controls angiogenesis in vitro and targets serum response factor. FEBS Letters. 585(19). 3095–3100. 63 indexed citations
18.
Wang, Wei, Sushovan Guha, Zhimin Tong, et al.. (2011). Target-Specific Agents Imaging Ectopic and Orthotopic Human Pancreatic Cancer Xenografts. Pancreas. 40(5). 689–694. 6 indexed citations
19.
Zhou, Lingyun, Ying Liu, Chaoxia Zou, et al.. (2010). The Effect of the Gly139His, Gly143His, and Ser142His Mouse Heme Oxygenase‐1 Mutants on the HO Reaction In Vivo and In Vitro. The Anatomical Record. 294(1). 112–118. 11 indexed citations
20.
Zou, Chaoxia. (2003). The oxidative carbonyl protein and carnosine protection. Zhongguo laonianxue zazhi. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026